Arrayjet’s ArrayPlex platform selected by Immunome for use in its discovery of targeted cancer therapies Post author: Post published: March 18, 2024 Post category:uncategorized Immunome signs deal to use Arrayjet platform in its in-house screening operations. You Might Also Like MRI-based computer models offer early insight into bone healing November 4, 2025 Study explores the impact of respiratory bacteria on RSV severity February 6, 2025 Using Swarm Learning approach to aid doctors in treating stroke patients June 5, 2025